Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pHL-EF1a-SphcCas9-iP-A Citations (11)

Originally described in: Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9.
Li HL, Fujimoto N, Sasakawa N, Shirai S, Ohkame T, Sakuma T, Tanaka M, Amano N, Watanabe A, Sakurai H, Yamamoto T, Yamanaka S, Hotta A Stem Cell Reports. 2014 Nov 25. pii: S2213-6711(14)00335-X. doi: 10.1016/j.stemcr.2014.10.013.
PubMed Journal

Articles Citing pHL-EF1a-SphcCas9-iP-A

Articles
Efficient genomic correction methods in human iPS cells using CRISPR-Cas9 system. Li HL, Gee P, Ishida K, Hotta A. Methods. 2015 Oct 23. pii: S1046-2023(15)30133-X. doi: 10.1016/j.ymeth.2015.10.015. PubMed
Identification of Small-Molecule PHD2 Zinc Finger Inhibitors that Activate Hypoxia Inducible Factor. Arsenault PR, Song D, Bergkamp M, Ravaschiere AM, Navalsky BE, Lieberman PM, Lee FS. Chembiochem. 2016 Dec 14;17(24):2316-2323. doi: 10.1002/cbic.201600493. Epub 2016 Nov 11. PubMed
Cell-type-specific genome editing with a microRNA-responsive CRISPR-Cas9 switch. Hirosawa M, Fujita Y, Parr CJC, Hayashi K, Kashida S, Hotta A, Woltjen K, Saito H. Nucleic Acids Res. 2017 May 19. doi: 10.1093/nar/gkx309. PubMed
A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4. Sasaki-Honda M, Jonouchi T, Arai M, Hotta A, Mitsuhashi S, Nishino I, Matsuda R, Sakurai H. Hum Mol Genet. 2018 Dec 1;27(23):4024-4035. doi: 10.1093/hmg/ddy293. PubMed
Cell-Type-Specific CRISPR Activation with MicroRNA-Responsive AcrllA4 Switch. Hirosawa M, Fujita Y, Saito H. ACS Synth Biol. 2019 Jul 19;8(7):1575-1582. doi: 10.1021/acssynbio.9b00073. Epub 2019 Jul 9. PubMed
In Vitro Modeling of the Bipolar Disorder and Schizophrenia Using Patient-Derived Induced Pluripotent Stem Cells with Copy Number Variations of PCDH15 and RELN. Ishii T, Ishikawa M, Fujimori K, Maeda T, Kushima I, Arioka Y, Mori D, Nakatake Y, Yamagata B, Nio S, Kato TA, Yang N, Wernig M, Kanba S, Mimura M, Ozaki N, Okano H. eNeuro. 2019 Oct 17;6(5). pii: ENEURO.0403-18.2019. doi: 10.1523/ENEURO.0403-18.2019. Print 2019 Sep/Oct. PubMed
Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons. Yokota M, Kakuta S, Shiga T, Ishikawa KI, Okano H, Hattori N, Akamatsu W, Koike M. Mol Brain. 2021 Mar 23;14(1):58. doi: 10.1186/s13041-021-00771-0. PubMed
Suppressor of cytokine signalling 3 (SOCS3) expressed in podocytes attenuates glomerulonephritis and suppresses autoantibody production in an imiquimod-induced lupus model. Fukuta M, Suzuki K, Kojima S, Yabe Y, Suzuki K, Iida K, Yamada H, Makino S, Iwata A, Tanaka S, Iwamoto T, Suto A, Nakagomi D, Wakashin H, Maezawa Y, Maezawa Y, Takemoto M, Asanuma K, Nakajima H. Lupus Sci Med. 2021 May;8(1). pii: 8/1/e000426. doi: 10.1136/lupus-2020-000426. PubMed
Trapping of CDC42 C-terminal variants in the Golgi drives pyrin inflammasome hyperactivation. Nishitani-Isa M, Mukai K, Honda Y, Nihira H, Tanaka T, Shibata H, Kodama K, Hiejima E, Izawa K, Kawasaki Y, Osawa M, Katata Y, Onodera S, Watanabe T, Uchida T, Kure S, Takita J, Ohara O, Saito MK, Nishikomori R, Taguchi T, Sasahara Y, Yasumi T. J Exp Med. 2022 Jun 6;219(6). pii: 213184. doi: 10.1084/jem.20211889. Epub 2022 Apr 28. PubMed
Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells. Ueda T, Shiina S, Iriguchi S, Terakura S, Kawai Y, Kabai R, Sakamoto S, Watanabe A, Ohara K, Wang B, Xu H, Minagawa A, Hotta A, Woltjen K, Uemura Y, Kodama Y, Seno H, Nakatsura T, Tamada K, Kaneko S. Nat Biomed Eng. 2023 Jan;7(1):24-37. doi: 10.1038/s41551-022-00969-0. Epub 2022 Dec 12. PubMed
Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells. Sanchez-Martin A, Sanchon-Sanchez P, Romero MR, Marin JJG, Briz O. Biomed Pharmacother. 2023 Sep;165:115209. doi: 10.1016/j.biopha.2023.115209. Epub 2023 Jul 25. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.